Available data types
Over the past two decades, thousands of molecular measurements have been generated from the NCI-60 cell lines, including:
- Transcriptomics:
- RNA-Seq
- DNA microarrays
- Genomics:
- Single Nucleotide Polymorphisms (SNPs)
- Copy Number Variants (CGH)
- Proteomics:
- Protein expression
- Enzyme activities
- Epigenetics:
- DNA methylation
- miRNA profiling
- Metabolomics and Mutation Data
These data were generated through collaborative studies via the DTP Molecular Targets Program and are continually updated.
Access DTP Molecular Targets Data
• Download Molecular Target Data
• Search Molecular Target Data
• Browse Molecular Target Data
Apply to Measure New Molecular Targets
Investigators may apply to perform additional molecular profiling on the NCI-60 panel using DTP-provided materials. This collaborative program supports the discovery of drug-target relationships, biomarkers, or mechanistic correlates.
What's Provided
- Frozen cell pellets (typically 1×10⁷ cells)
- Possible access to other NCI-60 materials (pending request)
- Data analysis support (optional)
- Option to link results with HTS384/COMPARE data
Application Requirements
Submit the following via email to moltarget@mail.nih.gov:
- Name, Institution, and Contact Info
- Molecular target(s) to be measured
- Proposed method and scientific rationale
- Requested materials and quantities
- Funding source and estimated timeline
- Agreement to return results and publish data per MTA
All applicants must complete a standard Material Transfer Agreement (MTA) and agree to share finalized data for public release following publication.
Integrating with Screening & COMPARE
Molecular target data can be:
- Used alongside HTS384 screening data to explore target-sensitivity correlations
- Integrated with COMPARE analysis to uncover potential shared mechanisms
- Mined to identify tumor subpanel-selective biomarkers (e.g., colon vs. melanoma)
Use case: Identify genes whose expression correlates with a compound’s GI50 pattern across the NCI-60.
Cell Line Reclassifications (Based on Molecular Profiling)
Recent omics studies led to updates in lineage assignments of certain NCI-60 lines:
- MDA-MB-435 & MDA-N → Melanoma, not breast cancer
- NCI/ADR-RES → Ovarian, not breast cancer
- SNB-19 & U251 → Derived from the same CNS tumor
These changes are based on consistent evidence from:
- Gene expression profiling
- SNP and CGH array data
- DNA fingerprinting and karyotype comparisons
Full details and citations are available in the Cell Line Identity Update.
Tools & Resources